Composition for the prevention and treatment of metabolic disorder containing benzazole derivatives as an active ingredient

A method for treating a metabolic disorder, comprising administering a therapeutically effective amount of the benzazole derivative represented by the following Chemical Formula 1 or a pharmaceutically acceptable salt thereof to a patient in need of treatment of metabolic disorder:

• (wherein,
• R1 is one substituent at position C5 or C6 of a benzoxazole or benzimidazole ring, which is selected from a group consisting of H, COORa, CONRbRc and SO2NH2,
• wherein Ra is H or a C1˜C2 alkyl group, and
• Rb and Rc are independently selected from a group consisting of:
• a C3˜C5 heteroaryl group bearing at least one heteroatom selected from among N, O and S;
• a C3˜C5 heterocyclic group bearing at least one heteroatom selected from among N, O and S;
• a C1˜C5 alkyl group bearing a C1˜C3 alkyl-substituted amino group;
• H;
• an amino group;
• and a C1˜C3 alkyl group;
• R2 is a C1˜C10 alkyl group, a halogen atom or a nitro group;
• R3 is H or a halogen atom;
• and
• X is O or NH).